Mitchell Liu
Overview
Explore the profile of Mitchell Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
2057
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baker S, Baker S, Leclerc C, Leclerc C, Atmanspacher-Wirth H, Atmanspacher-Wirth H, et al.
Int J Radiat Oncol Biol Phys
. 2025 Feb;
PMID: 39923903
Purpose/objectives: There are limited data on outcomes in patients with ultracentral pulmonary oligometastases treated with SABR. The purpose of this study was to determine whether ultracentral location was prognostic for...
2.
Lum-Wang S, Ingledew P, Carolan H, Dunne E, Chan E, Wang Y, et al.
J Cancer Educ
. 2024 Dec;
PMID: 39627645
Lung cancer remains the leading cause of cancer mortality. Meanwhile, the Internet remains a remarkably popular source of health information. This study characterizes how patients with lung cancer utilize online...
3.
Chang J, Dunne E, Baker S, Liu M
Radiother Oncol
. 2024 Oct;
201:110565.
PMID: 39353542
No abstract available.
4.
Abrina J, Baker S, Cruz-Lim E, Chng N, Ye A, Rathod S, et al.
Pract Radiat Oncol
. 2024 Sep;
PMID: 39303778
Purpose: The optimal SABR treatment delivery schedule in stage I non-small cell lung cancer (NSCLC) remains unclear. This population-based study investigated grade ≥2 toxicity rates, local failure (LF), and overall...
5.
Schellenberg D, Gabos Z, Duimering A, Debenham B, Fairchild A, Huang F, et al.
Int J Radiat Oncol Biol Phys
. 2024 Aug;
121(1):28-38.
PMID: 39168356
Purpose: This trial examined if patients with ≤5 sites of oligoprogression benefit from the addition of SABR to standard of care (SOC) systemic therapy. Methods And Materials: We enrolled patients...
6.
7.
Lee J, Kim J, Liu M, Bang A, Olson R, Chang J
J Breast Cancer
. 2024 Mar;
27(2):91-104.
PMID: 38529591
Purpose: To report on the local control and toxicity of 5-fraction, high-conformal ultrafractionated radiation therapy (RT) for primary tumors in patients with metastatic breast cancer (MBC) who did not undergo...
8.
Olson R, Abraham H, Leclerc C, Benny A, Baker S, Matthews Q, et al.
BMC Cancer
. 2024 Feb;
24(1):171.
PMID: 38310262
Background: Radiotherapy delivery regimens can vary between a single fraction (SF) and multiple fractions (MF) given daily for up to several weeks depending on the location of the cancer or...
9.
Baker S, Lechner L, Liu M, Chang J, Cruz-Lim E, Mou B, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jan;
118(5):1497-1506.
PMID: 38220069
Purpose: The optimal sequencing of local and systemic therapy for oligometastatic cancer has not been established. This study retrospectively compared progression-free survival (PFS), overall survival (OS), and SABR-related toxicity between...
10.
Rostamzadeh M, Thomas S, Camborde M, Karan T, Liu M, Ma R, et al.
J Appl Clin Med Phys
. 2023 Oct;
25(2):e14161.
PMID: 37789572
Purpose: To assess the feasibility of using the diaphragm as a surrogate for liver targets during MDTT. Methods: Diaphragm as surrogate for markers: a dome-shaped phantom with implanted markers was...